New‐Onset Device‐Detected Atrial Fibrillation in Patients With Atrial Floating Dipole Implantable Cardioverter‐Defibrillators: A Propensity Score‐Matched Comparison With Conventional Dual‐Chamber Systems
Open Access
- 2 April 2025
- journal article
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 36 (6) , 1303-1313
Abstract
Background: Device‐detected subclinical atrial fibrillation (DDAF) is a significant risk factor for major cardiovascular events, especially in implantable cardioverter‐defibrillator (ICD) recipients. The DX ICD, which utilizes a single ventricular lead with a floating atrial dipole, has demonstrated superior performance in diagnosing DDAF compared to conventional single‐lead ICDs. However, comparisons between DX and dual‐chamber (DDD) ICDs for atrial monitoring are limited.Objective: To compare the incidence of newly detected DDAF in patients without an indication for atrial pacing who received either a DX or a standard DDD ICD.Methods: Remote transmissions from the Italian Home Monitoring Expert Alliance dataset were analyzed. DDAF incidence for different burden cutoffs ( ≥ 15 min, ≥ 6 h, and ≥ 24 h) was compared between groups using propensity score (PS) matching to adjust for baseline characteristics.Results: In a cohort of 1329 patients (527 with DX ICD and 802 with DDD ICD), 30.7% experienced DDAF lasting ≥ 15 min, 22.3% ≥ 6 h, and 14.0% ≥ 24 h during a median follow‐up of 4.5 years. DDAF incidence was lower in the DX ICD group for all burden cutoffs (p < 0.0001). However, after PS matching, DDAF rates were similar between groups, with no significant differences (p ≥ 0.36). Multivariate analysis identified age and 1‐month right ventricular pacing percentage as predictors of DDAF across all burden cutoffs, with no effect based on device type or programmed basic rate.Conclusion: In patients without atrial pacing indication or history of clinical atrial fibrillation at implantation, the DX ICD demonstrated DDAF detection capabilities comparable to DDD ICDs in a real‐world setting.Keywords
This publication has 36 references indexed in Scilit:
- A prospective, multicenter, randomized controlled trial comparing VDD-ICD with VVI-ICD in detecting subclinical atrial fibrillation in patients with ICDs: The Dx-AF trialHeart Rhythm O2, 2024
- The utilization of atrial sensing dipole in single lead implantable cardioverter defibrillator for detection of new‐onset atrial high‐rate episodes or subclinical atrial fibrillation: A systematic review and meta‐analysisJournal of Arrhythmia, 2022
- Rate‐responsive pacing and atrial high rate episodes in cardiac resynchronization therapy patients: Is low heart rate the key?Clinical Cardiology, 2019
- Atrial high-rate episodes and risk of major adverse cardiovascular events in patients with cardiac implantable electronic devicesClinical Research in Cardiology, 2019
- Organizational model and reactions to alerts in remote monitoring of cardiac implantable electronic devices: A survey from the Home Monitoring Expert Alliance projectClinical Cardiology, 2018
- Does the CHA 2 DS 2 -VASc score reliably predict atrial arrhythmias? Analysis of a nationwide database of remote monitoring data transmitted daily from cardiac implantable electronic devicesHeart Rhythm, 2018
- Newly detected atrial high rate episodes predict long-term mortality outcomes in patients with permanent pacemakersHeart Rhythm, 2014
- Association of Single- vs Dual-Chamber ICDs With Mortality, Readmissions, and Complications Among Patients Receiving an ICD for Primary PreventionJAMA, 2013
- Newly detected atrial fibrillation in patients with an implantable cardioverter-defibrillator is a strong risk marker of increased mortalityHeart Rhythm, 2009
- Atrial fibrosis and the mechanisms of atrial fibrillationHeart Rhythm, 2007